Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald - 2027 is Most Visible
October 2, 2026 7:07 AM
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $270.00 price target on Tenet Healthcare (NYSE: THC).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
